ROYAL BANK OF CANADA - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 45 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 2.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$1,0000.0%2250.0%0.00%
Q1 2022$1,0000.0%2250.0%0.00%
Q4 2021$1,0000.0%225
-18.2%
0.00%
Q3 2021$1,000
-94.7%
275
-93.8%
0.00%
Q2 2021$19,000
+171.4%
4,410
+170.1%
0.00%
Q1 2021$7,0000.0%1,633
-6.9%
0.00%
Q4 2020$7,000
+600.0%
1,754
+549.6%
0.00%
Q3 2020$1,000270
+500.0%
0.00%
Q2 2020$0
-100.0%
45
-99.7%
0.00%
Q1 2020$65,000
-17.7%
15,608
-22.0%
0.00%
Q4 2019$79,000
+338.9%
20,000
+900.0%
0.00%
Q3 2019$18,000
-21.7%
2,000
-16.7%
0.00%
Q2 2019$23,000
+91.7%
2,400
+312.4%
0.00%
Q3 2018$12,000
+200.0%
582
+280.4%
0.00%
Q2 2018$4,000
-95.7%
153
-95.1%
0.00%
Q1 2018$93,000
+830.0%
3,102
+900.6%
0.00%
Q4 2017$10,000
-88.4%
310
-87.4%
0.00%
Q3 2017$86,000
+1620.0%
2,453
+1535.3%
0.00%
Q2 2017$5,000
-77.3%
150
-80.3%
0.00%
Q1 2017$22,000
+37.5%
762
-19.7%
0.00%
Q4 2016$16,000
-20.0%
949
+11.3%
0.00%
Q3 2016$20,000
+11.1%
853
-22.5%
0.00%
Q2 2016$18,000
-21.7%
1,1000.0%0.00%
Q1 2016$23,000
-23.3%
1,1000.0%0.00%
Q4 2015$30,000
+76.5%
1,100
+82.1%
0.00%
Q3 2015$17,000
-79.3%
604
-81.8%
0.00%
Q2 2015$82,000
+78.3%
3,322
+32.9%
0.00%
Q1 2015$46,0002,5000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders